SUVRETTA CAPITAL MANAGEMENT
Suvretta Capital Management is an investment management company.
SUVRETTA CAPITAL MANAGEMENT
Status:
Active
Contact:
212-702-5200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Apache Nginx GoDaddy DNS Ruby On Rails Token GoDaddy SSL
Similar Organizations
Artist Capital Management
Artist Capital Management is a global, growth-oriented investment management company.
Brooktree Capital Management
Brooktree Capital Management is an investment management company.
Fertitta Capital
Fertitta Capital is an investment firm.
MIG Capital
MIG Capital is an investment management company.
PRG Capital Management
PRG Capital Management is an investment management firm
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-12 | Prokidney | Suvretta Capital Management investment in Post-IPO Equity - Prokidney | 205 M USD |
| 2021-12-08 | connectRN | Suvretta Capital Management investment in Venture Round - connectRN | 76 M USD |
| 2021-12-07 | Freenome | Suvretta Capital Management investment in Series D - Freenome | 300 M USD |
| 2021-10-01 | Roivant Sciences | Suvretta Capital Management investment in Post-IPO Equity - Roivant Sciences | 200 M USD |
| 2021-07-06 | Alight Solutions | Suvretta Capital Management investment in Post-IPO Equity - Alight Solutions | 1.55 B USD |
| 2021-07-01 | Point Biopharma | Suvretta Capital Management investment in Post-IPO Equity - Point Biopharma | 165 M USD |
| 2021-06-30 | Turntide Technologies | Suvretta Capital Management investment in Convertible Note - Turntide Technologies | 225 M USD |
| 2021-03-31 | Paysafe | Suvretta Capital Management investment in Post-IPO Equity - Paysafe | 2 B USD |
| 2021-02-11 | Pipeline Therapeutics | Suvretta Capital Management investment in Series C - Pipeline Therapeutics | 80 M USD |
| 2021-02-10 | HemoShear Therapeutics | Suvretta Capital Management investment in Series A - HemoShear Therapeutics | 40 M USD |